About this document

Comirnaty Vaccine Overview and Efficacy by mrfjolly is a document available to read on EtoBox.

Comirnaty is a COVID-19 vaccine authorized for use in the EU. It contains mRNA that instructs cells to produce a spike protein found on the SARS-CoV-2 virus. Large clinical trials found it was 95% effective in preventing COVID-19. The most common side effects were mild like pain at the injection site. Additional studies are ongoing to provide more data on long term safety and effectiveness, including in children and pregnant women. Ongoing monitoring of the vaccine

Author

mrfjolly

Language

EN